leading glp-1 treatments for diabetes 2025 trends 2025: real-world data, patient outcomes & future therapies New GLP-1 Guidelines for Type

So, Tirzepatide dose-dependently reduced voluntary alcohol consumption, prevented binge and relapse-like drinking, Studies have shown reduced alcohol use in patients prescribed GLP-1 agonists

Fanelli G, Serretti A

The population was primarily between the ages of 45-64 (51.9%), female (55.5%), white (71.8%), and not Hispanic or Latino (82.9%)

Chemically, tirzepatide is a synthetic linear peptide containing 39 aminoacids based on the native GIP sequence

Theres no way to predict the outcome because we dont have research

Given the heterogeneity of this brain disease, available pharmacological treatments are effective only for a small group of people